SAB Biotherapeutics Cash Flow Statement (2020-2026) | SABS

Cash Flow Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-2.94M-4.06M-11.55M0.99M-4.78M-7.08M-7.85M-7.35M-6.88M-5.10M-22.86M-5.03M-7.34M-10.35M-10.00M-10.97M-10.45M-12.75M-14.57M-46.51M
Share-based Compensation (Quarter)
0.43M0.88M0.65M0.01M0.07M0.58M-1.97M0.00M0.64M0.64M-0.89M0.02M0.60M1.05M-0.34M0.61M5.20M0.80M-2.03M97.40M
Gains from Investment Securities (Quarter)
1.95M-0.00M5.65M-7.85M-1.73M-0.78M-0.04M-0.08M0.36M-0.18M4.73M-5.47M-2.22M-0.01M2.31M-5.04M0.63M-61.60M3.25M0.48M
Change in Interest Receivables (Quarter)
0.19M0.03M-0.13M-0.04M-0.03M-0.02M0.56M0.39M0.61M
Cash from Operations (Quarter)
-6.39M3.80M-4.88M-9.54M-4.45M-7.92M-1.56M-1.61M-4.90M-5.17M-13.45M-10.75M-7.72M-6.29M-9.53M-7.80M-7.15M-13.05M-16.78M-14.27M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.04M0.04M0.04M0.04M0.03M0.02M0.02M0.03M0.02M0.02M0.03M0.08M0.02M0.02M0.17M0.02M0.02M0.02M0.02M0.02M
Depreciation & Amortization (CF) (Quarter)
0.26M0.37M0.62M0.64M0.75M0.89M0.90M0.90M0.90M1.00M1.00M1.96M1.00M0.90M0.80M0.80M0.80M0.70M0.75M0.70M
Change in Working Capital
Change in Receivables (Quarter)
5.52M-6.90M-2.20M3.78M-2.17M3.33M-7.39M-4.79M-0.40M-0.36M
Change in Account Payables (Quarter)
-3.26M3.27M0.52M-0.04M-0.49M-2.23M-0.04M-0.32M-0.11M0.24M-0.05M0.13M0.59M0.68M0.14M0.34M0.32M0.11M
Change in Accured Expenses (Quarter)
-1.44M1.58M0.28M-0.60M-2.00M0.38M-0.32M-1.73M-0.76M-0.63M1.40M-1.58M-0.07M1.86M-1.44M0.58M1.04M-0.29M-0.39M-1.19M
Change in Taxes (Quarter)
0.09M
Investing Activities
Capital Expenditures (Quarter)
3.46M3.23M2.36M1.36M0.61M0.08M0.12M0.02M0.02M0.09M0.07M0.13M0.05M0.10M0.06M0.26M
Sales of Property, Plant and Equipment (Quarter)
0.08M0.04M500.000.00M
Change in Acquisitions & Divestments (Quarter)
3.75M10.69M4.74M5.25M11.27M74.60M
Cash from Investing Activities (Quarter)
-3.46M-3.23M-2.36M-1.28M-0.61M-0.08M-0.12M-0.02M-0.02M-0.04M-0.07M-31.36M11.22M-1.15M9.33M4.67M5.20M-129.87M-1.71M-65.65M
Financing Activities
Other financing activities (Quarter)
3.82M-4.17M0.01M0.07M1.00-1.000.00M0.00M59.65M0.02M-3.002.98M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
2.69M0.76M0.76M0.25M3.75M0.33M0.33M0.11M0.26M0.22M0.22M0.62M-0.53M0.14M0.14M3.00
Change in Capital Stock
Shares Issued (Quarter)
3.72M3.90M5.29M7.45M0.71M9.60M9.94M5.05M1.01M2.07M1.89M3.10M2.97M0.89M2.94M6.75M20.89M1.56M
Net Equity Issued and Repurchased (Quarter)
Misc.
Cash from Financing Activities (Quarter)
-0.05M-0.05M36.03M-6.32M-0.73M-0.29M8.39M-0.36M-0.36M-0.14M67.64M-0.39M-0.32M-0.67M0.22M-0.17M-0.17M168.69M-0.04M89.92M
Exchange Rate Effect (Quarter)
-0.03M0.03M0.05M-0.29M0.04M0.18M-0.04M-0.40M0.01M
Change in Cash (Quarter)
-9.90M0.52M28.79M-17.14M-5.79M-8.28M6.71M-1.99M-5.29M-5.35M54.14M-42.53M3.21M-8.07M-0.27M-3.26M-1.95M25.73M-18.92M10.02M
Free Cash Flow (Quarter)
-9.85M0.57M-7.24M-10.90M-5.06M-8.00M-1.67M-1.63M-4.92M-5.25M-13.51M-10.88M-7.77M-6.39M-9.59M-7.80M-7.15M-13.05M-16.78M-14.53M
Net Cash Flow (Quarter)
-9.90M0.52M28.79M-17.14M-5.79M-8.28M6.71M-1.99M-5.29M-5.35M54.12M-42.50M3.18M-8.12M0.02M-3.30M-2.13M25.77M-18.52M10.00M